Notices. Proposed rule; correction

378 words·~2 min read·/register/2019/04/18/2019-07712·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4910-13-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 201 [Docket No. FDA-1978-N-0018 (formerly Docket No. FDA-1978-N-0038)] RIN 0910-AF43 Sunscreen Drug Products for Over-the-Counter Human Use; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Proposed rule; correction. SUMMARY: The Food and Drug Administration

(FDA)is correcting a proposed rule relating to the regulation of over-the-counter

(OTC)sunscreen monograph products that appeared in the **Federal Register** of February 26, 2019. The document was published with formulas that were illegible. These corrections are being made to improve the accuracy of the proposed rule. DATES: Submit either electronic or written comments on the proposed rule by June 27, 2019. FOR FURTHER INFORMATION CONTACT: Kristen Hardin, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, Rm. 5443, Silver Spring, MD 20993, 240-402-4246. SUPPLEMENTARY INFORMATION: In the **Federal Register** of February 26, 2019 (84 FR 6204), in FR Doc. 2019-03019, on pages 6267 through 6270, the following corrections are made: 1. On page 6267, in the first column, the formula under § 201.327(i)(2)(ii)(B) is corrected to read: BILLING CODE 4164-01-P EP18AP19.004 2. On page 6268, in the second column, the formula under § 201.327(i)(3)(ii)(C)( *2* ) is corrected to read: EP18AP19.005 3. On page 6268, in the second column, the formulas under § 201.327(i)(3)(ii)(D)( *2* )( *i* ) are corrected to read: EP18AP19.006 4. On page 6269, in the third column, the formula under § 201.327(i)(7)(i) is corrected to read: EP18AP19.007 5. On page 6269, in the third column, the formulas under § 201.327(i)(7)(ii) are corrected to read: EP18AP19.008 6. On page 6270, in the second column, the formula under § 201.327(j)(4)(ii) is corrected to read: EP18AP19.009 7. On page 6270, in the third column, the formulas under § 201.327(j)(5)(i) are corrected to read: EP18AP19.010 8. On page 6270, in the third column, the formula under § 201.327(j)(7) is corrected to read: EP18AP19.011 9. On page 6270, in the third column, the formula under § 201.327(j)(8) is corrected to read: EP18AP19.012 Elsewhere in this issue of the **Federal Register** , FDA is extending the comment period on the proposed rule. Dated: April 12, 2019. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2019-07712 Filed 4-17-19; 8:45 am]

Connections1 off-index

1 reference not yet in our index

21 CFR 201

Citation graph

cites case law

Notices

Proposed rule; correction

Cite21 CFR 201

Cites 1Cited by 0 across 0 sources